National Health (Listed drugs on F1 or F2) Amendment Determination 2020 (No. 5) (PB 48 of 2020) (Cth)
PB 48 of 2020
National Health (Listed drugs on F1 or F2) Amendment Determination 2020 (No. 5)
National Health Act 1953
I, THEA DANIEL, Assistant Secretary, Pricing and PBS Policy Branch, Technology Assessment and Access Division, Department of Health, delegate of the Minister for Health, make this determination under subsection 85AB(1) of the National Health Act 1953.
Dated 29 May 2020
THEA DANIEL
Assistant Secretary
Pricing and PBS Policy Branch
Technology Assessment and Access Division
Department of Health
Part 1 Preliminary
Name of Determination
(1) This Determination is the National Health (Listed drugs on F1 or F2) Amendment Determination 2020 (No. 5).
(2) This Determination may also be cited as PB 48 of 2020.
Commencement
This Determination commences on 1 June 2020.
Amendment of National Health (Listed drugs on F1 or F2) Determination 2010
Schedule 1 amends the National Health (Listed drugs on F1 or F2) Determination 2010 (PB 93 of 2010).
Schedule 1 Amendments
(Section 3)
[1] Schedule 1, after item dealing with Amino acid formula with carbohydrate, vitamins, minerals and trace elements without phenylalanine
Insert
Amino acid formula with carbohydrate without phenylalanine
[2] Schedule 1, after item dealing with Amino acid formula with fat, carbohydrate, vitamins, minerals and trace elements without phenylalanine and tyrosine and supplemented with docosahexanoic acid
Insert
Amino acid formula with fat, carbohydrate without methionine
[3] Schedule 1, after item dealing with Amino acid formula with fat, carbohydrate without phenylalanine
Insert
Amino acid formula with fat, carbohydrate without phenylalanine and tyrosine
Amino acid formula with fat, carbohydrate without valine, leucine and isoleucine
[4] Schedule 1, after item dealing with Oxprenolol
Omit
Oxytocin
[5] Schedule 2, after item dealing with Dutasteride
Insert
Dutasteride with tamsulosin
0
0
0